Third Arc Bio

Third Arc Bio is a dynamic biotechnology research company dedicated to developing multifunctional antibodies that generate immune synapses. These synapses precisely activate or inhibit T cells, offering innovative approaches to therapeutic intervention. Located in Philadelphia, Pennsylvania, Third Arc Bio is committed to creating best-in-class T cell engagement through its advanced drug development engine. The company leverages two cutting-edge technology platforms: a solid tumor synergy platform and an I&I platform, which offers a novel approach to precision immune regulation at a tissue-specific level, ensuring superior efficacy and safety.

With a focus on delivering high-value therapeutics, Third Arc Bio is at the forefront of biotechnology innovation. The company’s primary address is in Philadelphia, Pennsylvania 19002, US, where they are developing groundbreaking solutions for complex medical challenges. Third Arc Bio's commitment to research and development aims to revolutionize treatment paradigms and improve patient outcomes. Through rigorous scientific inquiry and technological advancement, Third Arc Bio is setting new standards in the biotechnology industry.

Third Arc Bio continues to push the boundaries of biotechnology research, aiming to transform the landscape of immune-based therapies. The company is dedicated to creating novel solutions that address unmet medical needs and improve the lives of patients worldwide. We invite the management team at Third Arc Bio to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial reach.